根据条款,Harmony (HRMY)预计将以每股1.1059美元或6000万美元的现金收购Zynerba所有已发行股票。
根据某些临床、监管和销售里...查看全文
SeekingBiotech2023-08-14 21:36
$Harmony(HRMY)$ 收购$Zynerba制药(ZYNE)$
HRMY announced a definitive agreement to acquire Zynerba Pharmaceuticals for $1.1059 per share in cash, or $60 million, plus one non-tradeable contingent value right (CVR) per share, to receive potential additional payments of up t...查看全文
产业链观察2023-08-14 20:20
#药闻简讯# 2023年8月14日 -- 致力于为罕见神经疾病患者开发和商业化创新疗法的制药公司$Harmony(HRMY)$ 与$Zynerba制药(ZYNE)$ 达成的最终收购协议。
Zynerba 是针对包括脆性 X 综合征 (Fragile X syndrome, FXS) 在内的孤儿神经精神疾病开发创新透皮大麻素疗法的领先制药企业。
Zynerba ...查看全文
牛唐2021-02-07 16:49
$爵士制药(JAZZ)$ 收购了$吉瓦制药(GWPH)$ ,其他大麻制药概念股$Corbus制药控股(CRBP)$ 、$Zynerba制药(ZYNE)、$Cara Therapeutics(CARA)查看全文
牛唐2021-02-04 17:36
医药板块速评(2021.02.03)
1、AD药物继续疯狂,还有哪些AD概念股值得入手?$Cassava Sciences(SAVA)$
2、大麻药物概念股起飞,还有哪些相关概念股值得买入?$Zynerba制药(ZYNE)$
3、Reddit和WSB杀入医药板块,哪些概念股闻风而动?$SELLAS生命科学(SLS)$查看全文
chuminhua2020-07-02 21:32
6/30,Zynerba$Zynerba制药(ZYNE)$ 在宣布CBD(大麻素)凝胶在研药物Zygel用于罕见病脆性X综合征一项关键性III期研究 CONNECT-FX未达到主要终点和3个次要终点后,股价暴跌51%。这是这些年来该公司的CBD药物第4次在临床研究中失败。查看全文
Replix锐璞美股2020-04-08 16:56
$Zynerba制药(ZYNE)$ 小锐看了一下我们这段覆盖的药股,发现有一个共同的特征:管理层不!靠!谱!,比如我们覆盖的$Immunomedics(IMMU)$ $Avadel制药(AVDL)$ 还有Abeona Therapeutics。这些管理层全是坑爹货!说到ZYNE这家公司曾经因为大麻热而成为大热股票,但现在新鲜劲一过也被市场无情...查看全文
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ 美东时间 2016-06-07 16:30 Zynerba Pharmaceuticals Inc at Jefferies Healthcare Conference 网页链接
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ 8-K - Current report Filed: 2016-06-01 AccNo: 0001104659-16-124645 Size: 3 MBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ 8-K - Current report Filed: 2016-05-12 AccNo: 0001104659-16-120259 Size: 165 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-12 AccNo: 0001558370-16-005929 Size: 2 MB 网页链接
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-13 AccNo: 0001104659-16-111152 Size: 261 KB 网页链接
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ DEF 14A - Other definitive proxy statements Filed: 2016-04-13 AccNo: 0001104659-16-111140 Size: 643 KB 网页链接
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ 8-K - Current report Filed: 2016-04-04 AccNo: 0001104659-16-109406 Size: 3 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ PRE 14A - Other preliminary proxy statements Filed: 2016-03-14 AccNo: 0001104659-16-104933 Size: 643 KB 网页链接
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ 8-K - Current report Filed: 2016-03-14 AccNo: 0001104659-16-104631 Size: 3 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Zynerba Pharmaceuticals, Inc.(ZYNE)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-14 AccNo: 0001558370-16-004082 Size: 7 MB 网页链接